Nicole Meyer-Morse

University of California, Berkeley — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index4.2kcitations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Listeria monocytogenes in Food Safety(4), Immune Response and Inflammation(3), Angiogenesis and VEGF in Cancer(3), Immunotherapy and Immune Responses(2), Protease and Inhibitor Mechanisms(2)

Publications12 total

Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection
PLoS ONE·2010· 105 citedOpen Access
Suppression of Cell-Mediated Immunity following Recognition of Phagosome-Confined Bacteria
PLoS Pathogens·2009· 33 citedOpen Access
<i>Listeria monocytogenes</i> 6-Phosphogluconolactonase Mutants Induce Increased Activation of a Host Cytosolic Surveillance Pathway
Infection and Immunity·2009· 20 citedOpen Access
A bacterial pore-forming toxin forms aggregates in cells that resemble those associated with neurodegenerative diseases
Cellular Microbiology·2008· 19 citedOpen Access
Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen
PLoS Pathogens·2008· 211 citedOpen Access
Erratum: A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer
Oncogene·2005Open Access
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer
Oncogene·2005· 158 cited
Mice Lacking the Type I Interferon Receptor Are Resistant to <i>Listeria monocytogenes</i>
The Journal of Experimental Medicine·2004· 443 citedOpen Access
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
Cancer Cell·2004· 627 citedOpen Access
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Journal of Clinical Investigation·2003· 1.2k citedOpen Access
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
Journal of Clinical Investigation·2003· 1.2k cited
Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells
The Journal of Experimental Medicine·2003· 180 citedOpen Access

Frequent Co-authors

Douglas Hanahan(6), Daniel A. Portnoy(6), Emily K. Bergsland(3), Johanna A. Joyce(3), Gabriele Bergers(2), Steven Song(2), Dirk G. Brockstedt(2), Gregory Crimmins(2), Craig Freeman(2), Christopher R. Parish(2), Sofia N. Mochegova(2), Amos Baruch(1), Kareem A. H. Chehade(1), Enrico Giraudo(1), Fong-Ying Tsai(1), Doron C. Greenbaum(1), Jeffrey H. Hager(1), Matthew Bogyo(1), Victoria Auerbuch(1), Mary O’Riordan(1)